Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes

[1]  A. Zwinderman,et al.  High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events. , 2015, Atherosclerosis.

[2]  S. Genuth.  Response to Comment on Genuth. Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It’s Time to Move On! Diabetes Care 2015;38:170–175 , 2015, Diabetes Care.

[3]  Silvio E. Inzucchi,et al.  Metformin in patients with type 2 diabetes and kidney disease: a systematic review. , 2014, JAMA.

[4]  M. Abrahamson.  Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? Yes, They Continue to Serve Us Well! , 2014, Diabetes Care.

[5]  D. Matthews,et al.  Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2014, Diabetes Care.

[6]  J. Coresh,et al.  Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.

[7]  A. Hung,et al.  Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes. , 2014, JAMA.

[8]  H. Murff,et al.  Validation of VA administrative data algorithms for identifying cardiovascular disease hospitalization. , 2013, Epidemiology.

[9]  S. Inzucchi,et al.  Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2013, Diabetologia.

[10]  S. Inzucchi,et al.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379 , 2013, Diabetes Care.

[11]  R. Bilous,et al.  KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  Elizabeth Tarlov,et al.  Service utilization of veterans dually eligible for VA and Medicare fee-for-service: 1999-2004. , 2012, Medicare & medicaid research review.

[13]  Lizheng Shi,et al.  The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients. , 2012, Journal of diabetes and its complications.

[14]  M. Woodward,et al.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. , 2012, JAMA.

[15]  D. Matthews,et al.  Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach , 2012, Diabetes Care.

[16]  J. Kastelein,et al.  Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing? , 2011, Diabetes, obesity & metabolism.

[17]  L. Pogach,et al.  Risk of Hypoglycemia in Older Veterans with Dementia and Cognitive Impairment: Implications for Practice and Policy , 2011, Journal of the American Geriatrics Society.

[18]  H. Murff,et al.  Comparisons of Persistence and Durability Among Three Oral Antidiabetic Therapies Using Electronic Prescription‐Fill Data: The Impact of Adherence Requirements and Stockpiling , 2011, Clinical pharmacology and therapeutics.

[19]  A. Vaag,et al.  Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. , 2011, European heart journal.

[20]  David M. Smith,et al.  Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 Diabetes , 2011, Diabetes Care.

[21]  Elias Brandt,et al.  Comparative Effectiveness Research in DARTNet Primary Care Practices: Point of Care Data Collection on Hypoglycemia and Over-the-Counter and Herbal Use Among Patients Diagnosed With Diabetes , 2010, Medical care.

[22]  Michael E. Miller,et al.  The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study , 2010, BMJ : British Medical Journal.

[23]  K. Murray,et al.  A computer case definition for sudden cardiac death , 2009, Pharmacoepidemiology and drug safety.

[24]  M. Valenstein,et al.  Suicide mortality among patients receiving care in the veterans health administration health system. , 2009, American journal of epidemiology.

[25]  G. Sundkvist,et al.  Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4‐year follow‐up , 2008, Diabetes, obesity & metabolism.

[26]  C. Camargo,et al.  Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits , 2008, BMC endocrine disorders.

[27]  F. Weaver,et al.  Veterans’ Access to and Use of Medicare and Veterans Affairs Health Care , 2007, Medical care.

[28]  M. Cheang,et al.  Validity of a Prescription Claims Database to Estimate Medication Adherence in Older Persons , 2006, Medical care.

[29]  C. Maynard,et al.  Accuracy and completeness of mortality data in the Department of Veterans Affairs , 2006, Population health metrics.

[30]  R. Grymonpre,et al.  Pharmaceutical Use among Older Adults: Using Administrative Data to Examine Medication-Related Issues , 2005, Canadian Journal on Aging / La Revue canadienne du vieillissement.

[31]  Rury R Holman,et al.  Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). , 2002, Diabetes care.

[32]  W A Ray,et al.  Antipsychotics and the risk of sudden cardiac death. , 2001, Archives of general psychiatry.

[33]  D. Rubin,et al.  Estimating and Using Propensity Scores with Partially Missing Data , 2000 .

[34]  W. Ray,et al.  Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. , 1997, Archives of internal medicine.

[35]  J. Pugh,et al.  Is Combination Sulfonylurea and Insulin Therapy Useful in NIDDM Patients?: A metaanalysis , 1992, Diabetes Care.

[36]  Lori S. Parsons.  Reducing Bias in a Propensity Score Matched-Pair Sample Using Greedy Matching Techniques , 2001 .